Advertisements


Eli Lilly"s Trulicity shows promise in delivering efficacy in type 2 diabetes

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 23rd, 2018

Study of Lilly"s Humulin R U-500 shows improved response in type 2 diabetes

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 25th, 2018

Eli Lilly updates Trulicity label to show efficacy in CKD, include AWARD-7 trial

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJul 19th, 2018

Tuberculosis Vaccine Could Reverse Type 1 Diabetes, Study Shows

Just two jabs reverses diabetes even in people who have had the Type 1 form for decades. The causes of Type 1 diabetes can be significantly reversed over several years with just two injections of a common .....»»

Category: europeSource: fortuneJun 21st, 2018

New Diabetes Research for Off-the-Shelf Cell Transplants Shows Promise

Researchers at Georgia Tech found a way to bypass rejection of pancreatic cell transplants by encasing them in a hydrogel shield. Could this challenge the future of insulin injections?Related Stocks: NVO, SNY, LLY, MESO,.....»»

Category: blogSource: gurufocusJun 13th, 2018

Eli Lilly Scores a Win in Diabetes

A new study may give sales of one of its diabetes drugs a boost......»»

Category: topSource: foxnewsJul 20th, 2018

J&J"s (JNJ) Phase III Study for Invokana Halted Earlier

Johnson & Johnson's (JNJ) phase III CREDENCE study evaluating the efficacy and safety of its diabetes drug Invokana is being stopped early based on positive pre-specified efficacy data. Johnson & Johnson JNJ .....»»

Category: personnelSource: nytJul 17th, 2018

Next Avenue: This popular diet trend actually shows promise

The research on intermittent fasting indicates it might be a good strategy, even if you’re over 50......»»

Category: topSource: marketwatchJul 16th, 2018

Minerva Shows Cautious Promise Within A Difficult Indication

Minerva Shows Cautious Promise Within A Difficult Indication.....»»

Category: topSource: seekingalphaJul 9th, 2018

Viral immunotherapy to treat brain tumors in children shows promise

A viral immunotherapy using a herpes virus to treat brain tumors has been shown to be safe and well-tolerated in a pediatric study from UAB and Children’s of Alabama.  The findings managed to show preliminary evidence of effectiveness in killing .....»»

Category: topSource: bizjournalsJul 5th, 2018

LYV Stock Shows Promise, But it’s a No-Go at These Levels

InvestorPlace - Stock Market News, Stock Advice & Trading Tips LYV is simply too expensive to be a buy right now. Live Nation Entertainment's future prospects look.....»»

Category: topSource: investorplaceJul 5th, 2018

Alder says PROMISE 2 data of Eptinezumab demonstrates improvement in efficacy

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 29th, 2018

Alder says PROMISE 1 trial data demonstrates long-term efficacy of Eptinezumab

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 29th, 2018

Merck (MRK) Presents New Data from Januvia Diabetes Studies

Merck (MRK) produces new data from two studies on type II diabetes medicine Januvia (sitagliptin), which supports the drug's clinical profile. Merck & Co., Inc MRK presented new data from two studies, evaluating its type II di.....»»

Category: dealsSource: nytJun 25th, 2018

America Movil Shows Promise With Core Focus, Risks Remain

American Movil (AMX) has launched 4.5G networks in Brazil, Mexico, Austria and Dominicana that can deliver speed up to 10 times faster than 4G, On Jun 25, we issued an updated res.....»»

Category: smallbizSource: nytJun 25th, 2018

Amgen"s Repatha Reduces Bad Cholestrol in Type II Diabetes

Amgen's (AMGN) Repatha signi.....»»

Category: smallbizSource: nytJun 25th, 2018

Real-World data show advantages in people treated with Eli Lilly"s Trulicity

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 24th, 2018

New data reinforce potential of Eli Lilly"s Ultra Rapid Lispro in diabetes

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 24th, 2018

Merck presents new data from comparative trials in Type 2 diabetes

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 24th, 2018

Amgen"s Repatha "significantly reduced" LDL-C, non-HDL-C in Type 2 diabetes

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 23rd, 2018

Oppenheimer: After FDA Approval Of Tandem"s Insulin Pump, Investor Focus Will Shift To 2018 Opportunities

Late Thursday, Tandem Diabetes Care Inc (NASDAQ: TNDM) announced FDA approval of its t:slim X2 insulin pump with Basal-IQ for Type 1 diabetes patients, which is planned for an August launch. Latest Ratings for TND.....»»

Category: blogSource: benzingaJun 22nd, 2018